Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

Published:2014-04 Issue:4 Volume:14 Page:291-300
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Pollard Richard B,Rockstroh Jürgen K,Pantaleo Giuseppe,Asmuth David M,Peters Barry,Lazzarin Adriano,Garcia Felipe,Ellefsen Kim,Podzamczer Daniel,van Lunzen Jan,Arastéh Keikawus,Schürmann Dirk,Clotet Bonaventura,Hardy W David,Mitsuyasu Ronald,Moyle Graeme,Plettenberg Andreas,Fisher Martin,Fätkenheuer Gerd,Fischl Margaret,Taiwo Babafemi,Baksaas Ingebjørg,Jolliffe Darren,Persson Stefan,Jelmert Øyvind,Hovden Arnt-Ove,Sommerfelt Maja A,Wendel-Hansen Vidar,Sørensen Birger

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference38 articles.

1. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies;Lancet,2008

2. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N Engl J Med,2011

3. The emerging race to cure HIV infections;Cohen;Science,2011

4. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation;Shan;Immunity,2012

5. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication;García;Sci Transl Med,2013

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zika virus precursor membrane peptides induce immune response in peripheral blood mononuclear cells;Human Immunology;2024-03

2. Strategies for HIV-1 suppression through key genes and cell therapy;Frontiers in Medicine;2023-11-29

3. Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure;Journal of Translational Medicine;2023-11-07

4. Recent advances in poor HIV immune reconstitution: what will the future look like?;Frontiers in Microbiology;2023-08-07

5. Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials;The Brazilian Journal of Infectious Diseases;2023-05